A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Barbara Ann Karmanos Cancer Institute
University of South Florida
European Organisation for Research and Treatment of Cancer - EORTC
Northwestern University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center